456 related articles for article (PubMed ID: 1875968)
1. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
2. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
3. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
5. Sun habits in kidney transplant recipients with skin cancer: a case-control study of possible causative factors.
Lindelöf B; Granath F; Dal H; Brandberg Y; Adami J; Ullén H
Acta Derm Venereol; 2003; 83(3):189-93. PubMed ID: 12816154
[TBL] [Abstract][Full Text] [Related]
6. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
7. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.
Zamanian A; Farshchian M
J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593
[TBL] [Abstract][Full Text] [Related]
9. The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage.
Aydingoz SE; Takemoto SK; Pinsky BW; Salvalaggio PR; Lentine KL; Willoughby L; Hoover B; Burroughs TA; Schnitzler MA; Graff R
Hum Immunol; 2007 Jun; 68(6):491-9. PubMed ID: 17509448
[TBL] [Abstract][Full Text] [Related]
10. Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients.
Moloney FJ; Almarzouqi E; O'Kelly P; Conlon P; Murphy GM
Arch Dermatol; 2005 Aug; 141(8):978-82. PubMed ID: 16103326
[TBL] [Abstract][Full Text] [Related]
11. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients.
Bavinck JN; Gissmann L; Claas FH; Van der Woude FJ; Persijn GG; Ter Schegget J; Vermeer BJ; Jochmus I; Müller M; Steger G
J Immunol; 1993 Aug; 151(3):1579-86. PubMed ID: 8393047
[TBL] [Abstract][Full Text] [Related]
12. The changing role of HLA matching.
Cecka JM
Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
[TBL] [Abstract][Full Text] [Related]
13. Squamous and basal cell carcinoma in heart transplant recipients.
Lampros TD; Cobanoglu A; Parker F; Ratkovec R; Norman DJ; Hershberger R
J Heart Lung Transplant; 1998 Jun; 17(6):586-91. PubMed ID: 9662094
[TBL] [Abstract][Full Text] [Related]
14. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
15. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
16. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW
N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242
[TBL] [Abstract][Full Text] [Related]
17. Skin cancer in liver transplant recipients.
Otley CC; Pittelkow MR
Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations in renal transplant recipients of Santiago, Chile.
Sandoval M; Ortiz M; Díaz C; Majerson D; Molgó M
Transplant Proc; 2009 Nov; 41(9):3752-4. PubMed ID: 19917380
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of dysplasia and malignant lip lesions in transplant patients.
Nolan A; Girdler NM; Seymour RA; Thomason JM
J Oral Pathol Med; 2012 Feb; 41(2):113-8. PubMed ID: 21883488
[TBL] [Abstract][Full Text] [Related]
20. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients.
Ho WL; Murphy GM
Br J Dermatol; 2008 Feb; 158(2):217-24. PubMed ID: 18070205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
